Expert recommendations highlight the importance of regular foot inspection, proper hygiene, and suitable footwear to prevent serious foot problems in individuals with nerve damage. Peripheral neuropathy can turn routine foot care into a matter of prevention rather than response. The…
Jasmine Varner’s dramatic 143kg weight loss following a type 2 diabetes diagnosis highlights how medical interventions and lifestyle changes are revolutionising severe obesity treatment. Jasmine Varner’s rapid weight loss has turned a once-limited daily routine into something far broader, after…
A tailored version of the DASH eating plan, called DASH4D, has been shown to significantly improve blood sugar markers in adults with type 2 diabetes, especially among those with higher initial A1c levels, according to Johns Hopkins research. A modified…
Researchers at the University of Pennsylvania harness artificial intelligence to examine over 410,000 Reddit posts, revealing possible overlooked side effects of popular diabetes and weight-loss medicines such as Ozempic and Wegovy, including menstrual and temperature-related symptoms. Researchers at the University…
Emerging evidence suggests potential in stem cell approaches to treat diabetes, yet clinical practice is hindered by limited approvals and ongoing trials amidst unproven claims. Stem cell therapy remains an experimental field in diabetes care, but the evidence base is…
New Danish research suggests that initiating statin therapy soon after a type 2 diabetes diagnosis may lower the long-term risk of developing dementia, highlighting potential benefits of early cholesterol management beyond cardiovascular health. People newly diagnosed with type 2 diabetes…
New research suggests that elevated cortisol may impair the effectiveness of GLP-1 incretin therapies in some patients, prompting calls for more nuanced diagnostic approaches to optimise diabetes treatment outcomes. GLP-1 drugs have become best known for weight loss, but they…
Dr. Elena Christofides highlights the role of cortisol dysregulation in influencing patient responses to incretin therapies, raising questions about personalised treatment approaches for type 2 diabetes. GLP-1 drugs have become best known for weight loss, but they were first developed…
Zealand Pharma has licensed its innovative diabetes peptide platform to US biotech Elvinix, aiming to develop a first-in-class regenerative treatment that targets the immune destruction of insulin-producing beta cells in type 1 diabetes, amid rising global demand. Zealand Pharma has…
While GLP-1 prescription drugs can aid in appetite control and broader health improvements, their use for weight management demands careful consideration of individual health profiles, potential side effects, and long-term planning beyond social media trends. Choosing a GLP-1 medicine for…
